Evidence map›Paper›PMID 42635770›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2026

Clinical Evaluation of [

Xingyu Mu, Shengyuan Xu, Zihao Chen, Hoi Yee Chow, Lei Zhang, Jingze Li, Chenchen Jiang, Jiamin Jin, Xuechen Li, Feng Xue and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Xingyu Mu *Department of Nuclear Medicine, The First Affiliated Hospital, Guilin Medical University, Guilin, 541001, China.
Shengyuan Xu *Department of Oncology, The First Affiliated Hospital, Guilin Medical University, Guilin, 541001, China.
Zihao Chen *Department of Nuclear Medicine, The First Affiliated Hospital, Guilin Medical University, Guilin, 541001, China.
Hoi Yee ChowSerilink Biotechnology Company Limited, Hong Kong, 999077, China.
Lei ZhangDepartment of Nuclear Medicine, The First Affiliated Hospital, Guilin Medical University, Guilin, 541001, China.
Jingze LiDepartment of Nuclear Medicine, The First Affiliated Hospital, Guilin Medical University, Guilin, 541001, China.
Chenchen JiangDepartment of Nuclear Medicine, The First Affiliated Hospital, Guilin Medical University, Guilin, 541001, China.
Jiamin JinKey Laboratory of Tumor Immunology and Microenvironmental Regulation, Guilin Medical University, Guilin, Guangxi, 541199, China.
Xuechen LiDepartment of Chemistry, State Key Laboratory of Synthetic Chemistry, The University of Hong Kong, Hong Kong, 999077, China. xuechenl@hku.hk.
Feng XueDepartment of Oncology, The First Affiliated Hospital, Guilin Medical University, Guilin, 541001, China. xuefeng_doctor@126.com.
Wei FuDepartment of Nuclear Medicine, The First Affiliated Hospital, Guilin Medical University, Guilin, 541001, China. fuwei19700513@163.com.ORCID http://orcid.org/0009-0000-5173-6331

Funding

Innovative Research Group Project of the National Natural Science Foundation of China 82460356National Natural Science Foundation of China 82402332Natural Science Foundation of Guangxi Zhuang Autonomous Region 2026GXNSFAA00640798the Natural Science Foundation of Guangxi Zhuang Autonomous Region 2025GXNSFHA069001
6 · The paper itself

Abstract

purposeThis prospective study evaluated the clinical performance of [

methodsBetween August 2025 and March 2026, 106 patients completed [

resultsThe final cohort comprised 106 patients (55 men, 51 women; mean age, 61.3 ± 9.0 years), including 102 malignant tumors and 4 benign lesions. Lesion [

conclusion[

Indexed as

[18F]AlF-NOTA-GL01[18F]FDGFAPIFibroblast activation proteinPET/CTSolid tumors

Identifiers

PMID42635770

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.